Form 4 for MRSH Marsh McLennan
Accepted 2025-03-07 00:00:00 ET · period of report 2025-03-06 · accession 0001127602-25-008675 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-03-07 | 2025-03-06 | MRSH | Jones John Jude | CMO | S - Sale+OE | $235.15 | -10.8K | 7,978 | -58% | -$2.55M |
| DM | 2025-03-07 | 2025-03-06 | MRSH | Jones John Jude | CMO | M - OptEx | $118.18 | +9,800 | 12.7K | +336% | +$1.16M |
| DM | 2025-03-07 | 2025-03-06 | MRSH | Jones John Jude | CMO | M - OptEx | $0.00 | -9,800 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-06 | S | D | 5,057 | $234.84 | 7,978 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $234.790 to $235.050. The price reported represents the weighted average sale price of these trades. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the shares sold at each separate price. |
| 2 | Common | Common Stock | 2025-03-06 | M | A | 5,057 | $117.53 | 13,035 | D | — | — | |
| 3 | Common | Common Stock | 2025-03-06 | S | D | 4,743 | $235.37 | 7,978 | D | — | — | |
| 4 | Common | Common Stock | 2025-03-06 | M | A | 4,743 | $118.87 | 12,721 | D | — | — | |
| 5 | Common | Common Stock | 2025-03-06 | S | D | 1,024 | $235.61 | 7,978 | D | — | — | |
| 6 | Derivative | Stock Options (Right to Buy) | 2025-03-06 | M | D | 5,057 | $0.00 | 0 | D | $117.53 · — to 2031-02-21 | 5,057 Common Stock | (F3) These options were granted on February 22, 2021 and vested in four equal annual installments on February 22nd of 2022, 2023, 2024 and 2025. |
| 7 | Derivative | Stock Options (Right to Buy) | 2025-03-06 | M | D | 4,743 | $0.00 | 0 | D | $118.87 · — to 2030-02-18 | 4,743 Common Stock | (F2) These options were granted on February 19, 2020 and vested in four equal annual installments on February 19th of 2021, 2022, 2023 and 2024 |